Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / DNAY - Despite 22% gain today Codex DNA still well down from June IPO price

DNAY - Despite 22% gain today Codex DNA still well down from June IPO price

Codex DNA Inc.
Despite double-digit gains today, Codex DNA (DNAY +22.7%) is still down ~38% from its IPO in June 2021. Its IPO was priced at $16. In afternoon trading today, shares stood at $9.33 Since the IPO, trading in Codex DNA has been volatile. Last month, Codex benefitted from a deal with Pfizer (PFE +0.7%) to develop mRNA vaccines and biotherapeutics. Seeking Alpha contributor Edmund Ingham called Codex a buy just after the Pfizer deal was announced.

For further details see:

Despite 22% gain today, Codex DNA still well down from June IPO price
Stock Information
Company Name: Codex DNA Inc.
Stock Symbol: DNAY
Market: NASDAQ
Menu
DNAY DNAY Quote DNAY Short DNAY News DNAY Articles DNAY Message Board
Get DNAY Alerts

News, Short Squeeze, Breakout and More Instantly...